CHKA and cancer: By using transcriptome analysis to identify candidate mechanisms that might account for CKI’s opposite effects on doxorubicin or 5-Fu in cancer cells, we have shown that our methods are effective and can be applied to complex situations, including drug interactions with complex mixtures or to compare different drug-drug interaction groups.